Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-31T17:19:37.128Z Has data issue: false hasContentIssue false
  • English
  • Français

Multiple system atrophy due to prolonged valproic acid treatment

Published online by Cambridge University Press:  23 April 2007

BARBARA BORRONI ,
ANNA ROSATI ,
CHIARA COSTANZI ,
ROBERTO ZULLI ,
DICRAM MARDIGHIAN ,
ROBERTO GASPAROTTI  and
ALESSANDRO PADOVANI
BARBARA BORRONI
Affiliation:
Neurology Unit, University of Brescia, Italy Email: [email protected]
ANNA ROSATI
Affiliation:
Neurology Unit, University of Brescia, Italy Email: [email protected]
CHIARA COSTANZI
Affiliation:
Neurology Unit, University of Brescia, Italy Email: [email protected]
ROBERTO ZULLI
Affiliation:
Neurology Unit, University of Brescia, Italy Email: [email protected]
DICRAM MARDIGHIAN
Affiliation:
Neurology Unit, University of Brescia, Italy Email: [email protected]
ROBERTO GASPAROTTI
Affiliation:
Neurology Unit, University of Brescia, Italy Email: [email protected]
ALESSANDRO PADOVANI
Affiliation:
Neurology Unit, University of Brescia, Italy Email: [email protected]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Studies reported in the literature indicate a wide range of movement disorders associated with anti-epileptic treatment (Easterford et al., 2004). Valproic acid is a well-known cause of reversible neurotoxicity characterized by symptoms resembling idiopathic Parkinson's disease (PD) and cognitive impairment (Armon et al., 1996; Onofrj et al., 1998).

Type
Letter
Information
International Psychogeriatrics , Volume 19 , Issue 4 , August 2007 , pp. 780 - 782
Copyright
International Psychogeriatric Association 2007